Determination of amphetamine, methamphetamine, and hydroxyamphetamine derivatives in urine by gas chromatography-mass spectrometry and its relation to CYP2D6 phenotype of drug users

Determination of amphetamine, methamphetamine, and hydroxyamphetamine derivatives in urine by gas chromatography-mass spectrometry and its relation to CYP2D6 phenotype of drug users / Elías Miranda-G, Monserrat Sordo, Ana María Serrano Salazar, Claudia Contreras, Leoncio Bautista, Aurora E Rojas García, Patricia Ostrosky-Wegman. - (Journal of Analytical Toxicology 31 (2007) 1 (January/February); p. 31-36).
- PMID: 17389081.
- DOI:10.1093/jat/31.1.31
___________________________________________________

Abstract

Amphetamine, a CYP2D6 substrate, is widely used by truck drivers, and the extent to which different people metabolize the drug has only been determined in an isolated or reduced number of samples. A gas chromatography-mass spectrometry method is implemented to simultaneously determine amphetamine, methamphetamine, and hydroxyamphetamine in the urine of drug users. This method is a useful contribution to a well-established field. The main improvements are the use of liquid-liquid extraction, the trapping of the amphetamines as their hydrochloride salt, as a solution to the volatility of these analytes, and its application to assess the CYP2D6 metabolic phenotype of amphetamine users, which is innovative. Calibration curves ranged from 125 to 1000 ng/mL and had an r(2) greater than 0.99. The validation data (precision, accuracy, and recovery) shows the reproducibility and selectiveness of the method. The method is applied to determine the metabolic ratio (MR) in 121 urine specimens of federal highway drivers who underwent random mandatory roadside testing for drugs. The statistical analysis of the MR shows the presence of three different groups, which according to the established groups for CYP2D6 and the amount of the drug metabolized, are classified into extensive metabolizers (EM), intermediate metabolizers (IM), and poor metabolizers (PM). The biological consequences of these differences in amphetamine metabolism, such as impaired driving, a risk to develop Parkinson's disease, or an addiction, need to be further studied.

show »
Type:
pdf

Parameters:

Science
Study
Date:
31 July 2006
People
Bautista, Leoncio
Contreras, Claudia
Miranda-G, Elías
Ostrosky-Wegman, Patricia
Rojas García, Aurora E.
Salazar, Ana María Serrano
Sordo, Monserrat
Country
Mexico
Language
English
Other organisations
Universidad Autónoma de Nayarit (UAN) - Autonomous University of Nayarit
Universidad Nacional Autónoma de México (UNAM) - National Autonomous University of Mexico
Analytical aspects
Isotope-ratio mass spectrometry (IRMS)
Testing method development
Doping classes
S6. Stimulants
Substances
Amphetamine
Hydroxyamfetamine
Methamphetamine(d-)
Document category
Scientific article
Document type
pdf
Category
  • Legal
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin